CoChat

Impact of a digital application on HbA1c levels in people with diabetes: a randomized controlled trial

Roth, Lena, Steckhan, Nico, Schwarz, Peter E. H. · 2025 · Frontiers in Digital Health
Cited by 6

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Aims: Digital applications have the potential to enhance diabetes management, particularly in patients treated with insulin. This study aims to evaluate the impact of a digital application on self-management (ESYSTA, Germany), expressed in a change in HbA1c levels, in people with diabetes treated with insulin. Materials and methods: A randomized controlled, multicentric trial was conducted in 204 people with diabetes (60% type 2 diabetes) treated with insulin to assess the efficacy of ESYSTA. Participants were randomly assigned to either the intervention group (IG) using ESYSTA in addition to the German standard of Care (SoC) according to the German disease management programs (DMP) for 6 months or a control group (CG) receiving SoC only. The primary endpoint was the change in HbA1c levels. Secondary endpoints included well-being and diabetes-related distress. Results: A clinically relevant reduction in HbA1c levels of on average −0.48% points (−0.66; −0.29) was observed in the IG after 6 months. Compared to the CG, this reduction was more pronounced, especially in the per-protocol sample [mean difference, −0.28% points; 95% CI (−0.54; −0.02)]. Improvements in the IG in further secondary endpoints, such as well-being or diabetes-related distress, indicate enhanced overall glycemic control and patient satisfaction in the IG. Conclusions: The use of ESYSTA improved HbA1c levels and other secondary outcomes in people with diabetes who are treated with insulin in comparison with German SoC in the context of DMP. These findings support the integration of digital tools in routine diabetes care to optimize patient outcomes. Clinical Trial Registration: https://drks.de/search/de/trial/DRKS00025996, identifier DRKS00025996.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fdgth.2025.1544668

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 37

  1. 2010, Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies, Lancet, 375, 2215, 10.1016/S0140-6736(10)60484-9 · DOI · Paper page
  2. IDF Diabetes Atlas 2021 - 10 Edition. (2021)
  3. Cosentino, 2020, 2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD), Eur Heart J, 41, 255, 10.1093/eurheartj/ehz486 · DOI · Paper page
  4. Zaharia, 2022, Comorbidities in recent-onset adult type 1 diabetes: a comparison of German cohorts, Front Endocrinol (Lausanne), 13, 760778, 10.3389/fendo.2022.760778 · DOI
  5. 2019, Diabetes in Germany - National Diabetes Surveillance Report 2019
  6. Schwarz, 2018, Blood sugar regulation as a key focus for cardiovascular health promotion and prevention: an umbrella review, J Am Coll Cardiol, 72, 1829, 10.1016/j.jacc.2018.07.081 · DOI · Paper page
  7. Grosser, 2023, Design of the DAVOS study: diabetes smartphone app, a fully automatic transmission of data from the blood glucose meter and insulin pens using wireless technology to enhance diabetes self-management—a study protocol for a randomized controlled trial, J Diabetes Sci Technol, 17, 742, 10.1177/19322968221075333 · DOI
  8. Brähler, 2007, Teststatistische Prüfung und Normierung der deutschen versionen des EUROHIS-QOL Lebensqualität-index und des WHO-5 Wohlbefindens-Index, Diagnostica, 53, 83, 10.1026/0012-1924.53.2.83 · DOI · Paper page
  9. Kamradt, 2014, Assessing self-management in patients with diabetes mellitus type 2 in Germany: validation of a German version of the summary of diabetes self-care activities measure (SDSCA-G), Health Qual Life Outcomes, 12, 185, 10.1186/s12955-014-0185-1 · DOI · Paper page
  10. Toobert, 2000, The summary of diabetes self-care activities measure: results from 7 studies and a revised scale, Diabetes Care, 23, 943, 10.2337/diacare.23.7.943 · DOI · Paper page
  11. van Hout, 2012, Interim scoring for the EQ-5D-5l: mapping the EQ-5D-5l to EQ-5D-3l value sets, Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research, 15, 10.1016/j.jval.2012.02.008 · DOI · Paper page
  12. 2024, R: A Language and Environment for Statistical Computing
  13. Bretschneider, 2023, Effectiveness of a digital health application for the treatment of diabetes type II—a pilot study, JCM, 12, 6317, 10.3390/jcm12196317 · DOI
  14. Kulzer, 2018, Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: results of the PDM-ProValue study program, Diabetes Res Clin Pract, 144, 200, 10.1016/j.diabres.2018.09.002 · DOI · Paper page
  15. Mora, 2017, Use of a novel, remotely connected diabetes management system is associated with increased treatment satisfaction, reduced diabetes distress, and improved glycemic control in individuals with insulin-treated diabetes: first results from the personal diabetes management study, Diabetes Technol Ther, 19, 715, 10.1089/dia.2017.0206 · DOI · Paper page
  16. Grady, 2015, Remote health consultations supported by a diabetes management web application with a new glucose meter demonstrates improved glycemic control, J Diabetes Sci Technol, 10, 737, 10.1177/1932296815622646 · DOI
  17. Mayer, 2019, 953-P: sustainable improvement in quality of blood glucose control in users of mySugr’s integrated diabetes management solution, Diabetes, 68, 953-P, 10.2337/db19-953-P · doi:10.2337/db19-953-p
  18. Ruissen, 2023, Clinical impact of an integrated e-health system for diabetes self-management support and shared decision making (POWER2DM): a randomised controlled trial, Diabetologia, 66, 2213, 10.1007/s00125-023-06006-2 · DOI · Paper page
  19. Ehrmann, 2024, Efficacy of a digital diabetes logbook for people with type 1, type 2, and gestational diabetes: results from a multicenter, open-label, parallel-group, randomized controlled trial, J Diabetes Sci Technol, 10.1177/19322968241239870 · DOI
  20. Holmen, 2014, A Mobile health intervention for self-management and lifestyle change for persons with type 2 diabetes, part 2: one-year results from the Norwegian randomized controlled trial RENEWING HEALTH, JMIR Mhealth Uhealth, 2, e57, 10.2196/mhealth.3882 · DOI · Paper page
  21. Clodi, 2019, Antihyperglykämische therapie bei diabetes mellitus typ 2 (update 2019), Wien Klin Wochenschr, 131, 27, 10.1007/s00508-019-1471-z · DOI
  22. Stratton, 2000, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, Br Med J, 321, 405, 10.1136/bmj.321.7258.405 · DOI · Paper page
  23. 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK prospective diabetes study (UKPDS) group, Lancet (London, England), 352, 837, 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
  24. McClure, 2018, Minimally important difference of the EQ-5D-5l Index score in adults with type 2 diabetes, Value Health, 21, 1090, 10.1016/j.jval.2018.02.007 · DOI · Paper page
  25. de Wit, 2022, Original research: how to identify clinically significant diabetes distress using the problem areas in diabetes (PAID) scale in adults with diabetes treated in primary or secondary care? Evidence for new cut points based on latent class analyses, BMJ Open, 12, 10.1136/bmjopen-2021-056304 · DOI
  26. Rubin, 1999, Quality of life and diabetes, Diabetes Metab Res Rev, 15, 205, 10.1002/(SICI)1520-7560(199905/06)15:3%3C205::AID-DMRR29%3E3.0.CO;2-O · DOI · Paper page
  27. Jacobson, 2004, Impact of improved glycemic control on quality of life in patients with diabetes, Endocr Pract, 10, 502, 10.4158/EP.10.6.502 · DOI
  28. 1999, Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). U.K. Prospective diabetes study group, Diabetes Care, 22, 1125, 10.2337/diacare.22.7.1125 · DOI · Paper page
  29. Bretschneider, 2023, Digitale gesundheitsanwendungen in der Diabetologie: Ein Überblick, Diabetes Aktuell, 21, 272, 10.1055/a-2149-1840 · DOI
  30. Heinemann, 2023, 984-P: importance and use of smart insulin pens with connectivity for diabetes management, Diabetes, 72, 984, 10.2337/db23-984-P · doi:10.2337/db23-984-p
  31. Roos, 2022, Level of digitalization in Germany: results of the diabetes digitalization and technology (D.U.T) report 2020, J Diabetes Sci Technol, 16, 144, 10.1177/1932296820965553 · DOI
  32. Heinemann, 2019, Benefit of digital tools used for integrated personalized diabetes management: results from the PDM-ProValue study program, J Diabetes Sci Technol, 14, 240, 10.1177/1932296819867686 · DOI
  33. Kolominsky-Rabas, 2022, Wie belastbar sind studien der aktuell dauerhaft aufgenommenen digitalen gesundheitsanwendungen (DiGA)? methodische qualität der studien zum nachweis positiver versorgungseffekte von DiGA, Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 175, 1, 10.1016/j.zefq.2022.09.008 · DOI
  34. Bos, 2023, Challenges with the use of digital sham: systematic review and recommendations, J Med Internet Res, 25, e44764, 10.2196/44764 · DOI
  35. Gossenheimer, 2023, The power of the placebo effect in diabetes: a systematic review and meta-analysis, Prim Care Diabetes, 17, 221, 10.1016/j.pcd.2023.03.006 · DOI
  36. Schrepp, 2017, Construction of a benchmark for the user experience questionnaire (UEQ), IJIMAI, 4, 40, 10.9781/ijimai.2017.445 · DOI · Paper page
  37. Schrepp, 2023, User Experience Questionnaire Handbook. All You Need to Know to Apply the UEQ Successfully in Your Projects

Cited by

Metadata

Authors
Roth, L., Steckhan, N., & Schwarz, P. E. H.
Venue
Frontiers in Digital Health
Published
2025-06-30
Volume
7
ISSN
2673-253X
Cited by
6
References
9

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.